Building
the future of
cancer screening
Building the future
of cancer screening
Detecting cancer early –
before symptoms occur
Canostix exploits the interaction of light and matter combined with state of the art data analysis in order to detect cancer early, when it can be cured.
Our aim is to allow anyone to get checked for a variety of cancers, simply by visiting the doctor they trust.
Detecting cancer early –
before symptoms occur
Canostix exploits the interaction of light and matter combined with state of the art data analysis in order to detect cancer early, when it can be cured.
Our aim is to allow anyone to get checked for a variety of cancers, simply by visiting the doctor they trust.
Screening exists for only 3% of cancers
9 in 10 patients diagnosed by screening are in an early stage, but so far only 6% of cancer diagnoses are made through screening
Screening exists for only 3% of cancers
9 in 10 patients diagnosed by screening are in an early stage, but so far only 6% of cancer diagnoses are made through screening
Early Detection is the key factor to survival
Ø 10-year survial for most common cancers
Expanding the horizon of cancer screening with photonics and big data
We are developing a simple blood test with an entirely new approach to cancer diagnosis.
We are developing a simple blood test with an entirely new approach to cancer diagnosis.
Instead of measuring only a few biomarkers, we take a chemical fingerprint of your blood and evaluate thousands of variables that are influenced by the disease.
Using highly sensitive vibrational spectroscopy enables us to measure even the slightest changes in the blood that are caused by the presence of the tumour.
By applying big data analytical algorithms based on thousands of patient samples, we are building predictive models that are capable of differentiating between patients with and without cancer with unprecedented accuracy.
Impact
THE IMPLICATIONS IF WE SUCCEED
Accessible
Low Cost
Increased Screening
More Cancer Types Detected
Reduced Mortalities
Accessible
Low Cost
Increased Screening
More Cancer Types Detected
Reduced Mortalities